about
Does HIV infection have an impact upon dental implant osseointegration? A systematic reviewChanges in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudineEffects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.Prevalence and associated factors of thrombocytopenia among HAART-naive HIV-positive patients at Gondar University Hospital, northwest Ethiopia.Hypocalcaemia, alcohol drinking and viroimmune responses in ART recipients.Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations.Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.HIV-1 protein induced modulation of primary human osteoblast differentiation and function via a Wnt/β-catenin-dependent mechanism.Smoking and HIV: time for a change?Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.Focal bone lesions in HIV-positive patient treated with tenofovirRecommendations for evaluation and management of bone disease in HIV.Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.Osteopenia and osteoporosis in people living with HIV: multiprofessional approachAntiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans.Administration of an activin receptor IIB ligand trap protects male juvenile rhesus macaques from simian immunodeficiency virus-associated bone loss.Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral DensitometryAssociation between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patientsCase report: A man on antiretroviral therapy with painful thighsEffects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patientsBone-derived mesenchymal stromal cells from HIV transgenic mice exhibit altered proliferation, differentiation capacity and paracrine functions along with impaired therapeutic potential in kidney injury.Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy.Smoking and HIV: prevalence, health risks, and cessation strategies.Renal dysfunction in the setting of HIV/AIDS.Endocrine and metabolic abnormalities among HIV-infected patients: a current review.Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model.Bone mineral density in people living with HIV: a narrative review of the literature.Osteoporosis and HIV.HIV Infection, Antiretroviral Therapy and Cardiovascular Risk.Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of ExerciseThe Aging Skeleton: Differences Between HIV-Infected Patients and the Uninfected Aging Population
P2860
Q27021653-16BAA97E-6EC5-4A0B-AF80-7BE4BCAD4D06Q28728374-2599373D-12D7-4F4D-873D-F7B34E2A6490Q33411216-05D9D327-0944-4F4A-BAEF-838CD9ED16CEQ33412453-FB4169CC-E52B-427A-9179-18CC202630B2Q33981464-23E24DF7-5F65-43D6-9D70-083C36E263B2Q34024085-24091A34-2EE1-463A-B2F8-66D7026D9C7CQ34158739-CCE87856-543A-4450-AFE2-5E3D0C4A34BBQ34529322-693F2DB5-C098-4A6C-8AFB-3FEA5BB41BE1Q34557147-E40B4E33-224C-4D3C-9C86-DF88AA0A4359Q34786514-6E9EF683-3D08-441D-A0C4-C1B9274523D6Q35068359-204B7F6D-513C-4CA6-B48F-6065EC9D85F9Q35112499-14B997BA-4C35-4E71-8F07-7AF4E295BBC3Q35451868-F270950B-5FD9-4790-A2E0-752F267FF0E0Q35557338-0C6B939F-6839-4563-9212-CC603C5F6F0AQ35671760-D1AACFFA-FB1F-4029-B4E6-5F0D47F228D4Q35859876-F4F699D1-59C7-4CB5-B61F-22712C065AF9Q36263420-8A3D47D5-C04A-4698-AF06-E74A1C88EB6AQ36685956-628FBCF1-036A-43A0-8C0A-52DDE8482939Q36688486-A1F8B6E0-76F8-447A-B728-B7DADE9211F4Q36841457-350E690B-76EF-4E0D-8B61-8DA9A087E9DEQ36931691-E494F33B-8D9A-4EA4-BCA8-7BC06C82DEC6Q37189938-DEB1E61A-2A24-42C5-B980-CAA8136CBEBCQ37855310-D2FC2965-32E9-4F59-A6BC-0FFBEAB9A28EQ38012348-D98C5845-3BE3-4103-A238-F099F3DFCEE1Q38019428-8F7A6E20-0E38-4B62-85E9-A584F2132465Q38130907-CBCF4EEF-DE49-43FD-B3B0-62AEF586ACA7Q38895284-298BAA94-9C02-4BF0-9DE9-6CAD0A322A8AQ40107245-ABB0BB27-0F8D-49AB-88CA-3A2B9470EB01Q44324866-9D408679-D1F7-41D0-9773-BF42A1E3E33CQ55210420-D5E122F5-6E52-4D75-9FC6-A586ABF5FDCCQ56984507-789FDD7F-A55E-4252-9A81-C5EACF982C92Q58797971-9EA04DB0-AC3C-4AC8-AC7C-28788B516B72
P2860
description
article
@en
im Juli 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2009
@uk
name
Metabolic bone disease in HIV infection
@en
Metabolic bone disease in HIV infection
@nl
type
label
Metabolic bone disease in HIV infection
@en
Metabolic bone disease in HIV infection
@nl
prefLabel
Metabolic bone disease in HIV infection
@en
Metabolic bone disease in HIV infection
@nl
P2093
P1433
P1476
Metabolic bone disease in HIV infection
@en
P2093
Carlo Biagetti
Davide Gibellini
Elisa De Crignis
Fabio Vescini
Laura Cimatti
Livia Tampellini
Marco Borderi
P304
P356
10.1097/QAD.0B013E32832CE85A
P407
P577
2009-07-01T00:00:00Z